wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q34333814-A345D9BB-3BC4-4284-B218-70626A5C86C8
Q34333814-A345D9BB-3BC4-4284-B218-70626A5C86C8
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34333814-A345D9BB-3BC4-4284-B218-70626A5C86C8
A randomized, double-blind, active control, multicenter, dose-finding study of lipegfilgrastim (XM22) in breast cancer patients receiving myelosuppressive therapy.
P2860
Q34333814-A345D9BB-3BC4-4284-B218-70626A5C86C8
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34333814-A345D9BB-3BC4-4284-B218-70626A5C86C8
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
d53d839de8505abc71b47e37fc5c7e4b71b9f06a
P2860
First and subsequent cycle use of pegfilgrastim prevents febrile neutropenia in patients with breast cancer: a multicenter, double-blind, placebo-controlled phase III study.